Comparison of Compounded Topical Anesthetics

Last updated: November 1, 2024
Sponsor: Dartmouth-Hitchcock Medical Center
Overall Status: Active - Recruiting

Phase

4

Condition

N/A

Treatment

BLT

Lidocaine topical

Clinical Study ID

NCT06569537
STUDY02002464
  • Ages 18-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men and women over 18, but not more than 75 years of age.

  • Patients who have a regularly scheduled dermatology appointment for Intense PulseLight (IPL), Pulse Dye Laser (PDL), or microneedling.

Exclusion

Exclusion Criteria:

  • Any subject who has a previous history of allergy, sensitivity, and contraindicationto benzocaine, lidocaine, or tetracaine.

  • Patients with cardiac/respiratory disease, seizure disorder, or neuropathies.

  • Patients who are under treatment for a dermatologic condition that may interferewith the evaluation of the study.

  • Pregnant women and women who are breastfeeding.

  • Patients who report concurrent use of anxiolytics or opiates, which may interferewith the interpretation of results.

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: BLT
Phase: 4
Study Start date:
October 22, 2024
Estimated Completion Date:
September 30, 2026

Connect with a study center

  • Dartmouth Hitchcock Dermatology Clinic

    Lebanon, New Hampshire 03766
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.